Workshop Program
The event will operate on Queensland time / AEST / UTC+10h / GMT+10h
This program is subject to change as we will be adding more presentations and setting the workshop hours.
27th of March 2020 |
||
Time | Title & Speaker | Duration |
11:30 – | Registration |
– |
12:45 – 13:00 | Welcome and Introduction |
15min |
13:00 – 13:25 | RCPA-QAP-external quality assessment update |
25min |
13:30 – 13:55 | Nordi QC-external quality assessment update |
25min |
14:00 – 14:25 | Medical laboratory accreditation: news and perspectives |
25min |
14:30 – 15:00 | Coffee break |
30min |
15:00 – 15:25 | Technical test approach: the pre-analytical phase |
25min |
15:30 – 15:55 | Technical test approach: the analytical phase |
25min |
16:00 – 16:25 | Technical test approach: the post- analytical phase |
25min |
16:30 – 17:00 | RCPA QAP: technical mock assessment |
30min |
18:30 – 20:30 | Cocktail Party |
2hrs |
28th of March 2020 |
||
Time | Title & Speaker | Duration | 7:30 – 8:45 | Roche Diagnostics Australia – PD-L1 Masterclass, discussing the PD-L1 landscape and testing within this space. |
75min |
9:00 – 9:25 | The tissue tool box: the journey from antibody to IHC assay |
25min |
9:30 – 9:55 | Cytokeratins in common practice: antibody selection, protocols and controls |
25min |
10:00 – 10:30 | Coffee Break |
30min |
The immunohistochemistry of the unknown primary cancer: approach, panels and NordiQC data |
25min | |
11:00 – 11:25 | Is there a role for immunohistochemistry in the diagnosis of skin adnexal tumors |
25min |
11:30 – 11:55 | Update on the use of immunohistochemistry for the diagnosis of melanocytic tumors |
25min |
12:00 – 12:25 | Breast markers review: An RCPA-QAP update |
25min |
12:30 – 13:00 | Lunch |
30min |
13:00 – 13:55 | PDL-1 immunohistochemistry: NordiQC companion module |
25min |
14:00 – 14:25 | The role of immunohistochemistry in gastrointestinal cancer classification: approach, panels and NordiQC data |
25min |
14:30 – 14:55 | Molecular biomarkers in endometrial hyperplasia |
25min |
15:00 – 15:30 | Coffee Break |
30min |
15:30 – 15:55 | Kappa and Lambda light chain assessment: Fit-for-purpose assay development |
25min |
16:00 – 16:25 | Multiplex IHC as a means to aide in the assessment of minimal residual disease (MRD) for plasma cell neoplasms |
25min |
16:30 – 17:00 | Open Forum: bring your problem cases and/or ask questions to: Nordi-QC, RCPA QAP, NATA. |
30min |
19:30 – | Drinks and Gala Dinner |
– |
29th of March 2020 |
||
Time | Title & Speaker | Duration |
8:20 | Gold Sponsors Morning Scientific Session |
– |
9:00 – 9:25 | The role of immunohistochemistry in vascular anomalies of childhood |
25min |
9:30 – 9:55 | Diagnostic challenges in vascular skin tumours |
25min |
10:00 – 10:25 | Immunohistochemistry on brain biopsy |
25min |
10:30 – 11:00 | Coffee Break |
30min |
11:00 – 11:25 | The role of immunohistochemistry in the diagnosis of paediatric brain tumours |
25min |
Markers for classification of lung cancer |
25min | |
12:00 – 12:25 | IHC and molecular diagnostics in non-small cell lung carcinoma |
25min |
Last update on: 2020/02/25 18:10:08 UTC/GMT time.